BIOMAT Database Logo BIOMAT Database Logo

Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy. 1976

S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1alpha-Hydroxycholecalciferol in renal osteodystrophy.
May 1977, Calcified tissue research,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.
May 1977, Calcified tissue research,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
July 1978, Israel journal of medical sciences,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
June 1977, Archives of disease in childhood,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
August 1976, Calcified tissue research,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
May 1977, Calcified tissue research,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
Therapeutic effects of 25-hydroxycholecalciferol and sodium etidronate on renal osteodystrophy.
February 1982, Mineral and electrolyte metabolism,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
January 1976, Nephron,
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1alpha-hydroxycholecalciferol and renal function.
September 1978, Lancet (London, England),
S Castells, and F Shai, and B Gauthier, and S E Hashemi, and C M Reddy, and H F De Luca
1-alpha-hydroxycholecalciferol for renal osteodystrophy.
October 1977, British medical journal,
Copied contents to your clipboard!